PositiveID partners with Rogers for diabetes management platform

PositiveID has partnered with Rogers Communications to improve diabetes management.

Through this relationship, Toronto-based Rogers Communications will provide PositiveID with machine-to-machine (M2M) wireless data and mobile connectivity management services to enable the communication of a diabetes patient's glucose readings from PositiveID's iglucose solution.

PositiveID's iglucose system is a mobile health platform designed to facilitate diabetes management by automatically creating logs and journals, which the American Diabetes Association says are an important assessment of an individual's response to his or her diabetes care plan. iglucose provides data to facilitate diabetes management by helping ensure patient compliance and data accuracy, and aiding in insurance reimbursement, according to the Delray Beach, Fla.-based developer of medical devices and biological detection systems.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup